Aditya Dhanawat shared on X:

“Our use of ICIs (standard and alternative dosing) in advanced gastric/gastroesophageal adenocarcinomas.”

The use of immune checkpoint inhibitors in advanced gastric/gastroesophageal adenocarcinomas – real-world evidence and the use of alternative dosing

Authors: Aditya Dhanawat, Mehak Trikha, Manan Vora, Himanshu Gujarathi, Vikas Ostwal, Prabhat Bhargava, Rajiv Kaushal, Anant Ramaswamy

Source: Aditya Dhanawat/X

Aditya Dhanawat is a DM resident in Medical Oncology at Tata Memorial Centre and an HBNI Fellow in Solid Tumor Oncology. He previously completed his residency in Internal Medicine at Kalinga Institute of Medical Sciences, India.

Aditya Dhanawat: ICIs in advanced gastric/gastroesophageal adenocarcinomas